Cargando…
Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus
OBJECTIVE: Diabetic retinopathy is a common complication of type 2 diabetes mellitus (T2DM). Due to the limited effectiveness of current prevention and treatment methods, new biomarkers are urgently needed for the prevention and diagnosis of DR. This study aimed to explore the relationships between...
Autores principales: | Wang, Wan-Ying, Liu, Xu, Gao, Xiao-Qian, Li, Xin, Fang, Zhong-Ze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964487/ https://www.ncbi.nlm.nih.gov/pubmed/35370967 http://dx.doi.org/10.3389/fendo.2022.834205 |
Ejemplares similares
-
The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus
por: Zhao, Shuo, et al.
Publicado: (2020) -
Plasma acylcarnitine and diabetic retinopathy: A study from Eastern China
por: Jin, Dongzhen, et al.
Publicado: (2022) -
Relationship between plasma glutamate and cardiovascular disease risk in Chinese patients with type 2 diabetes mellitus by gender
por: Li, Ru-Tao, et al.
Publicado: (2023) -
The Association of Homocysteine and Diabetic Retinopathy in Homocysteine Cycle in Chinese Patients With Type 2 Diabetes
por: Luo, Wei-Ming, et al.
Publicado: (2022) -
Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model
por: Wang, Qian, et al.
Publicado: (2022)